Virtual Care for Cardiometabolic Diseases: HCP and Patient Adoption

The benefits of Virtual Care solutions in the cardiometabolic space have been known long before the global pandemic made ‘virtual care’ a household phrase. Despite proven clinical outcomes and regulatory approvals, HCP and patient adoption remains slim. Join us in this informal conversation where we will discuss the main challenges around HCP and patient adoption of Virtual Care solutions for cardiometabolic diseases.

More specifically, in this session we will talk about: 

• Current levels of adoption of these solutions

• How to increase HCP and patient awareness, drive activation and ensure proper onboarding to virtual care products

• Virtual care solutions integration into physicians’ tools (like EMR, CDSS, etc) and workflow: challenges and best practices